Allan E Stolarski, MD MS
Site: Boston University Chobanian & Avedisian School of Medicine
Research Mentors: Daniel Remick, MD, and Peter Burke, MD
Area of Research: Investigated sepsis phenotypes and mechanisms of improved survival and organ function with HAT therapy (hydrocortisone, ascorbic acid, and thiamine) in septic shock.
Dr. Allan Stolarski is currently a General Surgery Resident and Clinical Instructor of General Surgery at Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center (BMC). He was previously the NIH-funded Immunobiology of Trauma research fellow at BUSM-BMC. As a surgeon-scientist, Dr. Stolarski was funded by an NIH T32GM86308 grant spending two years with 100% protected research time working on multiple NIH-funded investigations under the mentorship of Drs. Daniel Remick and Peter Burke. Additionally, Dr. Stolarski was independently awarded the Boston Trauma Institute grant in 2021-2022 to support his research on critically ill trauma patients. His passion and research focus is on surgical critical care including advancing the care of critically ill trauma patients. Dr. Stolarski has served as an investigator in the successfully completed NIH R21DK108145-NIH/NIDDK pilot randomized controlled trial into the role of early metabolic support for critically ill trauma patients with Dr. Peter Burke (PI). In addition to his role in the NIH-funded clinical nutrition study, Dr. Stolarski has garnished immense experience investigating novel therapies for sepsis as well as septic and inflammatory phenotypes including the use of machine learning and murine sepsis models supported by an additional R21 grant (PI: Remick) as well as two of Dr. Daniel Remick’s R01 grants (R01HL141513 and R01AI129966). Dr. Stolarski is an author of nearly 40 publications and book chapters, 17 of which he is the first author.
Top Three publications:
Stolarski AE, Young L, Weinberg J, Kim J, Lusczek E, Remick DG, Bistrian B, Burke P. Early metabolic support for critically ill trauma patients: A prospective randomized controlled trial. J Trauma Acute Care Surg. 2022 Feb 1;92(2):255-265. PMID:34739002.
Stolarski AE, Kim J, Rop K, Wee K, Zhang Q, Remick DG. Machine Learning and Murine Models Explain Failures of Clinical Sepsis Trials. J Trauma Acute Care Surg. Accepted for Publication April 2022.
Stolarski AE, Kim J, Zhang Q, Remick DG. Cytokine Drizzle – The Rationale for Abandoning “Cytokine Storm”. Shock. 2021 Nov 1;56(5):667-672. doi: 10.1097/SHK.0000000000001769. PMID: 34652339
- Boston Trauma Institute Grant
- NIH T32GM86308